SCHEMBL18875201

SCHEMBL18875201

c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2nc3ccccc3s2)ccc1-c1ccc(-c2nc3ccccc3s2)cc1N1c2ccccc2Sc2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.48
KDM4E B2RXH2 7/20 0.48
NPC1 O15118 6/20 0.48
MAPT P10636 6/20 0.48
SMN1; SMN2 Q16637 6/20 0.48
ALDH1A1 P00352 5/20 0.48
NFKB1 P19838 4/20 0.48
NFKB2 Q00653 4/20 0.48
RELA Q04206 4/20 0.48
LMNA P02545 3/20 0.48
TP53 P04637 3/20 0.48
HSD17B10 Q99714 3/20 0.48
HPGD P15428 3/20 0.48
PKM P14618 2/20 0.48
TDP2 O95551 1/20 0.43
APP P05067 6/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
POLB P06746 2/20 0.41
GLA P06280 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18875138 0.93 RAB9A (0.54) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL18875232 0.91 NPC1 (0.41) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL18875246 0.91 NPC1 (0.41) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL18875300 0.91 RAB9A (0.41) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL18875200 0.83 RAB9A (0.44) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL18875190 0.83 NPC1 (0.46) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL18875207 0.83 KDM4E (0.41) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL18875142 0.81 RAB9A (0.41) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL18875167 0.81 RAB9A (0.41) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL18875238 0.80 RAB9A (0.49) RAB9AKDM4ENPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME OR10J3, PPOX, OR51E2 RAB9A 2603/4885KDM4E 2416/4885NPC1 3621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.